Researchers at the University of Oxford will begin studying AbbVie's drug, Humira, as a potential treatment for COVID-19 patients, the university announced Sept. 30. The trial will enroll up to 750 people from nursing home settings in the U.K. The university ...
from Google Alert - health https://ift.tt/3l2EOr9
via IFTTT
0 comments:
Post a Comment